2018 NIH/NCATS-Lilly Fellowship Program Project Proposal

2018 NIH/NCATS-Lilly Fellowship Program Project Proposal

NCATS and Eli Lilly are accepting applications for the third round of its externship program. This 6 month externship aims to increase the skill sets of translational science trainees in drug development and to learn from another sector in the translational research ecosystem. NCATS continues to promote innovative partnerships among different stakeholders in translation.

Click program announcement for the purpose and goals of the externship, and how to submit an application. It is expected that at the end of this externship that participants (coming from academia) will understand the work, “language” and culture of another part of the translational ecosystem (industry) and contribute to the growth of an interdisciplinary translational workforce that can promote cooperation and collaboration among academic and industry stakeholders.

Eli Lilly has identified two to three projects in the areas of clinical pharmacology and  PK/PD that selected participants will have the opportunity in which to work.  Due to the confidential nature of the work being done at Eli Lilly, selected candidates will need to sign a non-disclosure agreement should a scholar/trainee from your institution be selected. However, this externship doesn’t preclude publication of non-confidential results.

Online applications must be received by April 16th, 2018

Please contact Dr. Joan Nagel with any questions joandav@mail.nih.gov.

Katherine Storms
kstorms@mcw.edu


NIH Funding Acknowledgment: Important Reminder – Please acknowledge the NIH when publishing papers, patents, projects, and presentations resulting from the use of CTSI resources by including the NIH Funding Acknowledgement.

PARTNERS

Zablocki VA Medical CenterMedical College of WisconsinMSOE